What Pharma Can Do About Brexit: Views From The C-Suite

London-based pharma consultancy Novasecta systematically researched the implications of the Brexit vote over the three-month period since the UK referendum vote in late June. The firm shares insights from its conversations with pharma company execs, and offers advice on managing in these uncertain times.